{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:48:03Z","timestamp":1783014483913,"version":"3.54.6"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genome Var"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tuberous sclerosis complex (TSC) is an autosomal dominant disease caused by loss-of-function mutations in either of two tumor suppressor genes, <jats:italic>TSC1<\/jats:italic> and <jats:italic>TSC2<\/jats:italic>. These mutations lead to the growth of benign tumors and hamartomas in many organs, including those of the central nervous system, the skin, and the kidneys. To investigate the genotype-phenotype correlation, we performed sequence analysis of the <jats:italic>TSC1<\/jats:italic>\/<jats:italic>2<\/jats:italic> genes using next-generation sequencing. We classified 30 patients with TSC whose pathogenic variants were identified into two groups: those with mutations producing premature termination codons (PTCs) and those with missense mutations. Then, we compared the phenotypes between the two groups. Patients with a PTC were significantly more likely to manifest the major symptoms of the diagnostic criteria than those without a PTC (<jats:italic>P<\/jats:italic>\u2009=\u20090.035). The frequencies of subependymal nodules (<jats:italic>P<\/jats:italic>\u2009=\u20090.026), cortical tubers (<jats:italic>P<\/jats:italic>\u2009=\u20090.026), and renal cysts (<jats:italic>P<\/jats:italic>\u2009=\u20090.026) were significantly higher in PTC-containing variants than in cases without a PTC. When the analyses were limited to renal angiomyolipoma (AML) cases with <jats:italic>TSC2<\/jats:italic> mutations, there was no difference in tumor size between cases with and without a PTC. However, the cases with a PTC showed a trend toward disease onset at a younger age and multiple tumors, and bilateral disease was observed in their AML lesions. TSC patients with PTC-producing mutations might potentially manifest more severe TSC phenotypes than those with missense mutations. A larger-scale study with appropriate samples deserves further investigation.<\/jats:p>","DOI":"10.1038\/s41439-022-00181-1","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T10:14:47Z","timestamp":1644488087000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Genotype-phenotype correlation of renal lesions in the tuberous sclerosis complex"],"prefix":"10.1038","volume":"9","author":[{"given":"Yoshinari","family":"Muto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sumitomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2383-0619","authenticated-orcid":false,"given":"Hidehito","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takema","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Miyai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kurahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Shiroki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"181_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","volume":"615","author":"JP Osborne","year":"1991","unstructured":"Osborne, J. P., Fryer, A. & Webb, D. Epidemiology of tuberous sclerosis. Ann. N. Y. Acad. Sci. 615, 125\u20137 (1991).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"181_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino, P. B., Nathanson, K. L. & Henske, E. P. The tuberous sclerosis complex. N. Engl. J. Med. 355, 1345\u201356 (2006).","journal-title":"N. Engl. J. Med."},{"key":"181_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/gcc.2870130411","volume":"13","author":"EP Henske","year":"1995","unstructured":"Henske, E. P. et al. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosom. Cancer 13, 295\u20138 (1995).","journal-title":"Genes Chromosom. Cancer"},{"issue":"8","key":"181_CR4","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","volume":"66","author":"CW Shepherd","year":"1991","unstructured":"Shepherd, C. W. et al. Causes of death in patients with tuberous sclerosis. Mayo Clin. Proc. 66(8), 792\u20136 (1991).","journal-title":"Mayo Clin. Proc."},{"key":"181_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/GIM.0b013e31803068c7","volume":"9","author":"KS Au","year":"2007","unstructured":"Au, K. S. et al. Genotype\/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med. 9, 88\u2013100 (2007).","journal-title":"Genet Med."},{"key":"181_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s10038-020-00839-0","volume":"66","author":"Y Meng","year":"2021","unstructured":"Meng, Y. et al. Mutation landscape of TSC1\/TSC2 in Chinese patients with tuberous sclerosis complex. J. Hum. Genet 66, 227\u2013236 (2021).","journal-title":"J. Hum. Genet"},{"key":"181_CR7","unstructured":"TSC COMPLEX SUBUNIT 2; TSC2. https:\/\/www.omim.org\/entry\/191092 (2020)."},{"key":"181_CR8","doi-asserted-by":"publisher","first-page":"e1005637","DOI":"10.1371\/journal.pgen.1005637","volume":"11","author":"ME Tyburczy","year":"2015","unstructured":"Tyburczy, M. E. et al. Mosaic and intronic mutations in TSC1\/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing. PLoS Genet 11, e1005637 (2015).","journal-title":"PLoS Genet"},{"key":"181_CR9","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson Jr.","year":"1971","unstructured":"Knudson, A. G. Jr. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68, 820\u20133 (1971).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"181_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15816","volume":"8","author":"KR Martin","year":"2017","unstructured":"Martin, K. R. et al. The genomic landscape of tuberous sclerosis complex. Nat. Commun. 8, 15816 (2017).","journal-title":"Nat. Commun."},{"key":"181_CR11","doi-asserted-by":"publisher","first-page":"e0185713","DOI":"10.1371\/journal.pone.0185713","volume":"12","author":"C Rosset","year":"2017","unstructured":"Rosset, C. et al. Molecular analysis of TSC1 and TSC2 genes and phenotypic correlations in Brazilian families with tuberous sclerosis. PLoS One 12, e0185713 (2017).","journal-title":"PLoS One"},{"key":"181_CR12","doi-asserted-by":"publisher","first-page":"e1006242","DOI":"10.1371\/journal.pgen.1006242","volume":"12","author":"K Giannikou","year":"2016","unstructured":"Giannikou, K. et al. Whole exome sequencing identifies TSC1\/TSC2 biallelic loss as the primary and sufficient driver event for renal angiomyolipoma development. PLoS Genet 12, e1006242 (2016).","journal-title":"PLoS Genet"},{"key":"181_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.humpath.2018.07.017","volume":"82","author":"S Li","year":"2018","unstructured":"Li, S. et al. Genotype-phenotype correlation of patients with tuberous sclerosis complex-associated renal angiomyolipoma: a descriptive study. Hum. Pathol. 82, 61\u201367 (2018).","journal-title":"Hum. Pathol."},{"key":"181_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49814-6","volume":"9","author":"J Ni","year":"2019","unstructured":"Ni, J. et al. Mutational analysis of renal angiomyolipoma associated with tuberous sclerosis complex and the outcome of short-term everolimus therapy. Sci. Rep. 9, 14337 (2019).","journal-title":"Sci. Rep."},{"key":"181_CR15","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrm3454","volume":"13","author":"S Kervestin","year":"2012","unstructured":"Kervestin, S. & Jacobson, A. NMD: a multifaceted response to premature translational termination. Nat. Rev. Mol. Cell Biol. 13, 700\u201312 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"181_CR16","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1016\/j.jmb.2013.07.014","volume":"425","author":"S Stefl","year":"2013","unstructured":"Stefl, S. et al. Molecular mechanisms of disease-causing missense mutations. J. Mol. Biol. 425, 3919\u201336 (2013).","journal-title":"J. Mol. Biol."},{"key":"181_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","volume":"49","author":"H Northrup","year":"2013","unstructured":"Northrup, H. & Krueger, D. A., G. International Tuberous Sclerosis Complex Consensus. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr. Neurol. 49, 243\u201354 (2013).","journal-title":"Pediatr. Neurol."},{"key":"181_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 17, 405\u201324 (2015).","journal-title":"Genet Med."},{"key":"181_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 48, 452\u20138 (2013).","journal-title":"Bone Marrow Transpl."},{"key":"181_CR20","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1086\/302381","volume":"64","author":"AC Jones","year":"1999","unstructured":"Jones, A. C. et al. Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am. J. Hum. Genet 64, 1305\u201315 (1999).","journal-title":"Am. J. Hum. Genet"},{"key":"181_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"SL Dabora","year":"2001","unstructured":"Dabora, S. L. et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am. J. Hum. Genet 68, 64\u201380 (2001).","journal-title":"Am. J. Hum. Genet"},{"key":"181_CR22","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/sj.ejhg.5201402","volume":"13","author":"O Sancak","year":"2005","unstructured":"Sancak, O. et al. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype\u2013phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex. Eur. J. Hum. Genet 13, 731\u201341. (2005).","journal-title":"Eur. J. Hum. Genet"},{"key":"181_CR23","doi-asserted-by":"publisher","first-page":"95516","DOI":"10.18632\/oncotarget.20764","volume":"8","author":"A Bongaarts","year":"2017","unstructured":"Bongaarts, A. et al. Subependymal giant cell astrocytomas in tuberous sclerosis complex have consistent TSC1\/TSC2 biallelic inactivation, and no BRAF mutations. Oncotarget 8, 95516\u201395529 (2017).","journal-title":"Oncotarget"}],"container-title":["Human Genome Variation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41439-022-00181-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41439-022-00181-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41439-022-00181-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T15:13:20Z","timestamp":1673622800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41439-022-00181-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["181"],"URL":"https:\/\/doi.org\/10.1038\/s41439-022-00181-1","relation":{},"ISSN":["2054-345X"],"issn-type":[{"value":"2054-345X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,10]]},"assertion":[{"value":"3 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"5"}}